PMID- 36186265 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20221004 IS - 0974-2727 (Print) IS - 0974-7826 (Electronic) IS - 0974-2727 (Linking) VI - 14 IP - 1 DP - 2022 Mar TI - An Immunoassay for Human Chorionic Gonadotropin in Cerebrospinal Fluid: Validation of a Modified-Approved Method for Accreditation by the College of American Pathologists. PG - 11-15 LID - 10.1055/s-0041-1733817 [doi] AB - Background Human chorionic gonadotropin (hCG) detection in cerebrospinal fluid (CSF) can provide additional value in the diagnosis of germinoma. However, matrix effects can influence the results when alternative sample types are used. Therefore, modified-cleared/approved methods, which are standard methods used outside their intended scope, are of interest. The aim of the present study was to establish a model to validate modified-approved methods in agreement with the College of American Pathologists (CAP) accreditation requirements. Methods Concentrations of hCG in CSF were determined by means of electrochemiluminescence immunoassay using a Roche Cobas e 602 immunoassay analyzer. Based on the intended use, the following performance characteristics were evaluated: precision, the limit of quantitation (LoQ), and the analytical measurement range (AMR). The reference interval (RI) was also established. For the clinical application study, CSF and serum hCG were measured in 10 patients diagnosed with germinoma. Results The intra- and inter-assay precisions at two levels (10, 250 IU/L) were 0.64 and 0.57% and 4.26 and 3.54%, respectively. The LoQ for hCG was determined to be 0.25 IU/L. The AMR was set from 0.2 to 1,200 IU/L. The RI for hCG in CSF was below 0.40 IU/L. The CSF hCG levels of 10 patients were all above 0.4 IU/L before therapy. Conclusion Modified-approved methods were validated and showed that the quality specifications of the medical laboratory have a positive value in the clinical context. The illustration of quantification of hCG in CSF resulted in compliance with the CAP accreditation requirements. CI - The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ). FAU - Hu, Yao AU - Hu Y AD - Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. FAU - Ni, Jiajin AU - Ni J AD - Department of Nursing, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. FAU - Zhang, Huating AU - Zhang H AD - Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. FAU - Wu, Wenqing AU - Wu W AD - Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. FAU - Chen, Yanwen AU - Chen Y AD - Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. FAU - Guan, Ming AU - Guan M AD - Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China. LA - eng PT - Journal Article DEP - 20210908 PL - Germany TA - J Lab Physicians JT - Journal of laboratory physicians JID - 101551511 PMC - PMC9519259 OTO - NOTNLM OT - cerebral spinal fluid OT - human chorionic gonadotropin OT - method validation COIS- Conflict of Interest None declared. EDAT- 2022/10/04 06:00 MHDA- 2022/10/04 06:01 PMCR- 2021/09/01 CRDT- 2022/10/03 04:31 PHST- 2022/10/03 04:31 [entrez] PHST- 2022/10/04 06:00 [pubmed] PHST- 2022/10/04 06:01 [medline] PHST- 2021/09/01 00:00 [pmc-release] AID - 2120556 [pii] AID - 10.1055/s-0041-1733817 [doi] PST - epublish SO - J Lab Physicians. 2021 Sep 8;14(1):11-15. doi: 10.1055/s-0041-1733817. eCollection 2022 Mar.